Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Biomarin Pharmaceutical Inc (NASDAQ:BMRN)

88.66
Delayed Data
As of 4:00pm ET
 +1.28 / +1.46%
Today’s Change
80.10
Today|||52-Week Range
100.51
+7.03%
Year-to-Date
7 Winners and Losers From Biggest Biotech Conference of 2017
11:03am / TheStreet.com - Paid Partner Content
4 Drug/Biotech Stocks That Could Be Buyout Targets in 2018
Dec 11 / Zacks.com - Paid Partner Content
Spark Therapeutics Stock Plunges on Hemophilia Therapy Data
Dec 12 / Zacks.com - Paid Partner Content
5 Health Care Stocks Gurus Are Buying
Dec 07 / GuruFocus News - Paid Partner Content
BioMarin Pharmaceutical (BMRN) Jumps: Stock Rises 7.5%
Dec 12 / Zacks.com - Paid Partner Content
Here's Why Sarepta Stock is Up More Than 70% in 6 Months
Dec 05 / Zacks.com - Paid Partner Content
Bluebird Bio Becoming Household Name With This Promising Cancer Treatment
Dec 11 / TheStreet.com - Paid Partner Content
 

Today’s Trading

Previous close87.38
Today’s open87.30
Day’s range86.43 - 89.27
Volume1,367,280
Average volume (3 months)1,334,019
Market cap$15.3B
Data as of 4:00pm ET, 12/13/2017

Growth & Valuation

Earnings growth (last year)-256.07%
Earnings growth (this year)+83.15%
Earnings growth (next 5 years)+81.00%
Revenue growth (last year)+27.18%
P/E ratioNM
Price/Sales12.40
Price/Book5.45

Competitors

 Today’s
change
Today’s
% change
MYLMylan NV+0.24+0.61%
PRGOPerrigo Company PLC+0.10+0.12%
JAZZJazz Pharmaceuticals...+0.08+0.06%
ALNYAlnylam Pharmaceutic...-2.43-1.91%
Data as of 4:15pm ET, 12/13/2017

Financials

Next reporting dateFebruary 22, 2018
EPS forecast (this quarter)-$0.27
Annual revenue (last year)$1.1B
Annual profit (last year)-$630.2M
Net profit margin-56.74%

Profile

Sector
Health Technology
Industry
Biotechnology
Chairman &
Chief Executive Officer
Jean-Jacques Bienaimé
Chief Financial Officer &
Executive Vice President
Dan Spiegelman
Corporate headquarters
San Rafael, California

Forecasts